Abeprazan (DWP14012) is a potassium-competitive acid blocker. Abeprazan inhibits H+, K+- ATPase by reversible potassium-competitive ionic binding with no acid activation required. Abeprazan is developed as a potential alternative to proton pump inhibitor for the treatment of acid-related diseases[1].
Molecular Weight:
410.41
Purity:
99.86
CAS Number:
[1902954-60-2]
Formula:
C19H17F3N2O3S
Target:
Proton Pump
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted